Figures & data
Figure 1 Enzymatic stages in distal cholesterol metabolites and their associated clinical disorders. Syndromic disorders occur with mutations in 7 of the 9 post-lanosterol steps in late cholesterol synthesis (indicated by bold/italics). A prominent cutaneous phenotype (ichthyosis) occurs in 6 of these diseases (indicated by bold/italics & underline).
![Figure 1 Enzymatic stages in distal cholesterol metabolites and their associated clinical disorders. Syndromic disorders occur with mutations in 7 of the 9 post-lanosterol steps in late cholesterol synthesis (indicated by bold/italics). A prominent cutaneous phenotype (ichthyosis) occurs in 6 of these diseases (indicated by bold/italics & underline).](/cms/asset/2016bcba-370d-430e-aed3-e66b19854014/kder_a_10914831_f0001.gif)
Figure 2 Pathogenesis-based therapy for disorders of distal cholesterol metabolites: Bases for improvement in clinical studies.
![Figure 2 Pathogenesis-based therapy for disorders of distal cholesterol metabolites: Bases for improvement in clinical studies.](/cms/asset/2b41ebee-9542-4444-91d4-c3bef6d1ff4c/kder_a_10914831_f0002.gif)
Table 1 Pathogenic mechanisms and potentially diagnostic features in disorders of distal cholesterol metabolism
Table 2 Pathogenesis and pathway-based therapy of inherited disorders of distal cholesterol metabolism